On the mechanism, aberrantly expressed Fbxo45 can sustain the ERK phosphorylation in NSCLC cells by degrading the specific ERK phosphatase STEP according to the analysis in Fbxo45‐silenced or ‐knockout cells (Fig. 3A–E). The gene discussed is FBXO45; the disease is non-small cell lung carcinoma.